Table 2 Objective responses after TACE and correlation with tumor marker responses
Radiologic response | AFP response | P value | DCP response | P value | ||
|---|---|---|---|---|---|---|
AFP responder | AFP non-responder | DCP responder | DCP non-responder | |||
(n = 91, 79.1%) | (n = 24, 20.9%) | (n = 77, 66.9%) | (n = 38, 33.1%) | |||
WHO criteria | 0.196 | 0.308 | ||||
Complete response | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||
Partial response | 17 (18.7) | 3 (12.5) | 11 (14.3) | 9 (23.7) | ||
Stable disease | 71 (78.0) | 18 (75.0) | 63 (81.8) | 26 (68.4) | ||
Progressive disease | 3 (3.3) | 3 (12.5) | 3 (3.9) | 3 (7.9) | ||
mRECIST criteria | ||||||
Complete response | 70 (76.9) | 13 (54.2) | 0.045 | 55 (71.4) | 28 (73.7) | 0.298 |
Partial response | 11 (12.1) | 3 (12.5) | 12 (15.6) | 2 (5.3) | ||
Stable disease | 3 (3.3) | 3 (12.5) | 4 (5.2) | 2 (5.3) | ||
Progressive disease | 7 (7.7) | 5 (20.8) | 6 (7.8) | 6 (15.7) | ||